These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20177820)

  • 1. Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.
    Alatri A; Foramitti M; Paoletti O; Zimmermann A; Testa S
    Intern Emerg Med; 2010 Aug; 5(4):359-60. PubMed ID: 20177820
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
    Webb DP; Warhoover MT; Eagle SS; Greelish JP; Zhao DX; Byrne JG
    J Extra Corpor Technol; 2008 Jun; 40(2):130-4. PubMed ID: 18705550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
    Makhija K; Chapman K; Prasad R
    Pathology; 2021 Oct; 53(6):800-802. PubMed ID: 33610318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
    Nielsen JD; Heslet L
    Ugeskr Laeger; 2009 Feb; 171(8):610-1. PubMed ID: 19284906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F
    Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].
    Lutz JT; Exner HJ; Schannewitzky A; Fehske W; Görlinger K
    Anaesthesist; 2008 Jan; 57(1):49-52. PubMed ID: 18209967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
    Lewis BE; Rangel Y; Fareed J
    Angiology; 1998 Jan; 49(1):61-7. PubMed ID: 9456166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ; Soffer J
    Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban].
    Heil S
    Anaesthesist; 2009 Nov; 58(11):1119-22. PubMed ID: 19795099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia and the health economic analysis of argatroban.
    Coventry DA; Webster NR
    Br J Anaesth; 2014 Jun; 112(6):964-7. PubMed ID: 24569065
    [No Abstract]   [Full Text] [Related]  

  • 13. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Iaffaldano R; McKiernan TL; Rao L; Donkin J; Wallenga JM
    Cathet Cardiovasc Diagn; 1996 Jun; 38(2):206-9. PubMed ID: 8776531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.
    Arnold RJ; Kim R; Tang B
    Cardiol Rev; 2006; 14(1):7-13. PubMed ID: 16371760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
    Marchetti M; Barelli S; Gleich T; Gomez FJ; Goodyer M; Grandoni F; Alberio L
    Br J Haematol; 2022 Jun; 197(6):766-790. PubMed ID: 35358358
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
    Ekbatani A; Asaro LR; Malinow AM
    Int J Obstet Anesth; 2010 Jan; 19(1):82-7. PubMed ID: 19625181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of heparin-induced thrombocytopenia: the initial management.
    Taylor LM; Smith KM
    Orthopedics; 2005 Jun; 28(6):559-62. PubMed ID: 16138467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.
    Benken ST; Tesoro EP; Kim KS; Mucksavage JJ
    Neurocrit Care; 2012 Oct; 17(2):177-82. PubMed ID: 22692920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.